Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China
· Delayed Price · Currency is CNY 44.50
+0.64 (1.46%)
Sep 29, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2008 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2008 - 2019 |
| Low Molecular Weight Heparin Preparations | 454.37M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Low Molecular Weight Heparin Preparations Growth | -41.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unfractionated Heparin Active Pharmaceutical Ingredients | 242.42M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unfractionated Heparin Active Pharmaceutical Ingredients Growth | -27.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Low Molecular Weight Heparin Raw Materials Medicine | 145.19M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Low Molecular Weight Heparin Raw Materials Medicine Growth | 31.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unfractionated Heparin Preparations | 54.46M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unfractionated Heparin Preparations Growth | 8.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 134.37M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -1.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2008 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2008 - 2019 |
| China | 751.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -37.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Abroad | 279.04M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Abroad Growth | 33.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|